{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:27:44Z","timestamp":1789597664517,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The European association of Urology (EAU) suggests a prognostic stratification of Upper Tract Urothelial Cancer (UTUC) based on high and low risk patients, with Radical nephroureterectomy (RNU) and bladder cuff resection being the gold standard for the treatment of non-metastatic High risk UTUC. However, no consensus on post-operative patient management or tools that predict who would benefit the most from a close follow-up rather than adjuvant chemotherapy regimen exist. in Machine Learning (ML) is gaining interest in Urology providing models for prognostic prediction purpose; It\u2019s role in UTUC has not yet been investigated. We aim to develop and validate multiple supervised ML models based on patient- and tumor- related features to predict prognosis in patients with preoperative Histological or Imaging proved UTUC treated with RNU within a multiethnic large cohort. Data from an international multicenter large cohort of histologically proven UTUC patients from Asia and Europe treated with RNU were retrospectively collected. Twenty different ML-supervised predictive models were first trained and then external validate with two separate set. Nomograms were constructed based on 8 independent prognostic factors (age, gender, grading, pT, pN, presence of Carcinoma in Situ (CIS), multifocality and Lymphovascular invasion(LVI)) to predict 6 Outcomes (Overall Survival (OS), Cancer Specific Survival (CSS) and Disease Free Survival (DFS) at 3 and 5 year). Performances were compared using Area-under-curve (AUC) of Receiver-Operating Characteristics (ROC). A total of 3129 patients were enrolled: 637 Asian Patients (training cohort) and 2492 European patients (validation cohort). Upon training assessment, LR models achieved the best results, being the best model for prediction of 4\/6 outcomes, with the best result in CSS both at 3 and 5 years (AUC: 0.85, 0.84, 0.81 for CSS-3y, CSS-5y and DFS-3y respectively). Upon external validation, LR(CSL) models achieve the best results, being the number 1 model for prediction of 3\/6 outcomes (AUC: 0.84, 0.79, 0.77 for CSS-3y, OS-3y and OS-5y respectively). ML is a promising technology in the field of UTUC. Our model achieve favorable results in terms of prediction of prognosis after RNU, especially in terms of CSS at 3 and 5 years, moreover is the first model of prognosis taking into account the differences in epidemiology existing between European and Asian patients. Further clinical validation and verification of its reliability for the case selection of adjuvant therapy are needed to assess its use in clinical practice linked to clinical decision making. ML is an advancing technology in the field of medicine and urology, which can also be applied to the definition of the prognosis of patients with UTUC undergoing RNU. Our study represents the first experience investigating this potential.<\/jats:p>","DOI":"10.1038\/s41598-025-29043-w","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:54:22Z","timestamp":1769054062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Training and external validation of machine learning supervised prognostic models of upper tract urothelial cancer (UTUC) after nephroureterectomy"],"prefix":"10.1038","volume":"16","author":[{"given":"Rossella","family":"Nicoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Ying","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spatafora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Ho-Ming","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Ching-Ho","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ho","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Lung","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin\u2011Chih","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Serni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"1","key":"29043_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/CAAC.21654","volume":"71","author":"R. L. Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. & Cancer Statistics CA Cancer J. Clin. 71 (1), 7\u201333. (2021). (2021). https:\/\/doi.org\/10.3322\/CAAC.21654","journal-title":"CA Cancer J. Clin."},{"key":"29043_CR2","unstructured":"\u2018Upper Urinary Tract Urothelial Cell Carcinoma - INTRODUCTION - Uroweb\u2019. Accessed: Feb. 28, 2023. [Online]. Available: https:\/\/uroweb.org\/guidelines\/upper-urinary-tract-urothelial-cell-carcinoma"},{"key":"29043_CR3","doi-asserted-by":"publisher","unstructured":"Birtle, A. et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395(10232), 1268\u20131277. https:\/\/doi.org\/10.1016\/S0140-6736(20)30415-3 (Apr. 2020).","DOI":"10.1016\/S0140-6736(20)30415-3"},{"issue":"11","key":"29043_CR4","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1002\/CAM4.2988","volume":"9","author":"T. Yoshida","year":"2020","unstructured":"Yoshida, T. et al. Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma. Cancer Med. 9 (11), 3733\u20133741 (2020). https:\/\/doi.org\/10.1002\/CAM4.2988","journal-title":"Cancer Med."},{"issue":"5","key":"29043_CR5","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/J.JURO.2012.10.057","volume":"189","author":"M. Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat, M. et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J. Urol. 189 (5), 1662\u20131669 (2013). https:\/\/doi.org\/10.1016\/J.JURO.2012.10.057","journal-title":"J. Urol."},{"key":"29043_CR6","doi-asserted-by":"publisher","unstructured":"Zhang, G. L. & Zhou, W. \u2018A Model for the Prediction of Survival in Patients With Upper Tract Urothelial Carcinoma After Surgery\u2019, Dose Response, 17(4), (2019). https:\/\/doi.org\/10.1177\/1559325819882872","DOI":"10.1177\/1559325819882872"},{"key":"29043_CR7","doi-asserted-by":"publisher","unstructured":"Krabbe, L. M. et al. Mar., \u2018Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma\u2019, J Urol, 197(3 Pt 1), 580\u2013589, (2017). https:\/\/doi.org\/10.1016\/J.JURO.2016.09.078","DOI":"10.1016\/J.JURO.2016.09.078"},{"issue":"4","key":"29043_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/J.EURURO.2012.01.021","volume":"61","author":"E. K. Cha","year":"2012","unstructured":"Cha, E. K. et al. Apr., \u2018Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma\u2019. Eur. Urol. 61 (4), 818\u2013825 (2012). https:\/\/doi.org\/10.1016\/J.EURURO.2012.01.021","journal-title":"Eur. Urol."},{"key":"29043_CR9","doi-asserted-by":"publisher","unstructured":"Yates, D. R. et al. Mar., \u2018Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram\u2019, Br J Cancer, 106(6), 1083\u20131088, (2012). https:\/\/doi.org\/10.1038\/BJC.2012.64","DOI":"10.1038\/BJC.2012.64"},{"issue":"5","key":"29043_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/BJU.12631","volume":"114","author":"T. Seisen","year":"2014","unstructured":"Seisen, T. et al. Nov., \u2018Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis\u2019. BJU Int. 114 (5), 733\u2013740 (2014). https:\/\/doi.org\/10.1111\/BJU.12631","journal-title":"BJU Int."},{"issue":"5","key":"29043_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/BJC.2013.462","volume":"109","author":"J. H. Ku","year":"2013","unstructured":"Ku, J. H. et al. External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Br. J. Cancer. 109 (5), 1130\u20131136 (2013). https:\/\/doi.org\/10.1038\/BJC.2013.462","journal-title":"Br. J. Cancer"},{"issue":"8b","key":"29043_CR12","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1111\/j.1464-410X.2011.10188.x","volume":"108","author":"K. Matsumoto","year":"2011","unstructured":"Matsumoto, K. et al. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study\u2019, BJU Int, 108(8b), E304\u2013E309, (2011). https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10188.x","journal-title":"BJU Int"},{"key":"29043_CR13","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/1097-0142(20010415)91:8+<1636::AID-CNCR1176>3.0.CO;2-D","volume":"91","author":"D. J. Sargent","year":"2001","unstructured":"Sargent, D. J. \u2018Comparison of artificial neural networks with other statistical approaches\u2019, Cancer, 91(S8) 1636\u20131642, (2001). https:\/\/doi.org\/10.1002\/1097-0142(20010415)91:8+%3C1636::AID-CNCR1176%3E3.0.CO;2-D","journal-title":"Cancer"},{"issue":"14","key":"29043_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMRA1814259","volume":"380","author":"A. Rajkomar","year":"2019","unstructured":"Rajkomar, A., Dean, J. & Kohane, I. Machine Learning in Medicine, N Engl J Med, 380(14), 1347\u20131358, (2019). https:\/\/doi.org\/10.1056\/NEJMRA1814259","journal-title":"N Engl. J. Med."},{"key":"29043_CR15","first-page":"217","volume-title":"Reading and Understanding Multivariate Statistics","author":"RE Wright","year":"1995","unstructured":"Wright, R. E. \u2018Logistic regression.\u2019, in Reading and Understanding Multivariate Statistics., Washington, DC, US: American Psychological Association, 217\u2013244. (1995)."},{"issue":"3","key":"29043_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1109\/21.97458","volume":"21","author":"SR Safavian","year":"1991","unstructured":"Safavian, S. R. & Landgrebe, D. A survey of decision tree classifier methodology. IEEE Trans. Syst. Man. Cybern. 21 (3), 660\u2013674. https:\/\/doi.org\/10.1109\/21.97458 (1991).","journal-title":"IEEE Trans. Syst. Man. Cybern"},{"key":"29043_CR17","doi-asserted-by":"publisher","unstructured":"Breiman, L. \u2018Random forests\u2019, Mach Learn, 45(1) 5\u201332, (2001). https:\/\/doi.org\/10.1023\/A:1010933404324\/METRICS","DOI":"10.1023\/A:1010933404324\/METRICS"},{"key":"29043_CR18","doi-asserted-by":"publisher","unstructured":"Chen, T. & Guestrin, C. \u2018XGBoost: A Scalable Tree Boosting System\u2019, Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, https:\/\/doi.org\/10.1145\/2939672","DOI":"10.1145\/2939672"},{"key":"29043_CR19","unstructured":"Ke, G. et al. \u2018LightGBM: A Highly Efficient Gradient Boosting Decision Tree\u2019, Accessed: Feb. 28, 2023. [Online]. Available: https:\/\/github.com\/Microsoft\/LightGBM"},{"key":"29043_CR20","doi-asserted-by":"publisher","unstructured":"Dorogush, A. V., Ershov, V. & Gulin, A. \u2018CatBoost: gradient boosting with categorical features support\u2019, Oct. (2018). https:\/\/doi.org\/10.48550\/arxiv.1810.11363","DOI":"10.48550\/arxiv.1810.11363"},{"issue":"3","key":"29043_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00994018","volume":"20","author":"C. Cortes","year":"1995","unstructured":"Cortes, C., Vapnik, V. & Saitta, L. Support-vector networks, Mach. Learn. 20(3): 273\u2013297, (1995). https:\/\/doi.org\/10.1007\/BF00994018","journal-title":"Mach. Learn."},{"key":"29043_CR22","unstructured":"Thai-Nghe, N., Gantner, Z. & Schmidt-Thieme, L. \u2018Cost-Sensitive Learning Methods for Imbalanced Data\u2019, Accessed: Feb. 28, 2023. [Online]. Available: http:\/\/www.cs.waikato.ac.nz\/ml\/weka\/"},{"issue":"3","key":"29043_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","volume":"35","author":"F. Soria","year":"2017","unstructured":"Soria, F. et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J. Urol. 35 (3), 379\u2013387 (2017). https:\/\/doi.org\/10.1007\/s00345-016-1928-x","journal-title":"World J. Urol."},{"key":"29043_CR24","doi-asserted-by":"publisher","unstructured":"Cerde\u00f1a, J. P., Plaisime, M. V. & Tsai, J. From race-based to race-conscious medicine: how anti-racist uprisings call Us to act. Lancet 396, 1125\u20131128. https:\/\/doi.org\/10.1016\/S0140-6736(20)32076-6 (Oct. 2020).","DOI":"10.1016\/S0140-6736(20)32076-6"},{"issue":"4","key":"29043_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/S11548-017-1522-8","volume":"12","author":"X. Xu","year":"2017","unstructured":"Xu, X. et al. Three-dimensional texture features from intensity and high-order derivative maps for the discrimination between bladder tumors and wall tissues via MRI. Int. J. Comput. Assist. Radiol. Surg. 12 (4), 645\u2013656 (2017). https:\/\/doi.org\/10.1007\/S11548-017-1522-8","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"issue":"11","key":"29043_CR26","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1002\/MP.12510","volume":"44","author":"S. S. Garapati","year":"2017","unstructured":"Garapati, S. S. et al. Urinary bladder cancer staging in CT urography using machine learning. Med. Phys. 44 (11), 5814 (2017). https:\/\/doi.org\/10.1002\/MP.12510","journal-title":"Med. Phys."},{"key":"29043_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/J.COMPBIOMED.2015.05.015","volume":"63","author":"G. Wang","year":"2015","unstructured":"Wang, G., Lam, K. M., Deng, Z. & Choi, K. S. Prediction of mortality after radical cystectomy for bladder cancer by machine learning techniques. Comput. Biol. Med. 63, 124\u2013132 . (2015). https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2015.05.015","journal-title":"Comput. Biol. Med."},{"key":"29043_CR28","doi-asserted-by":"publisher","unstructured":"Lam, K. M., He, X. J. & Choi, K. S. \u2018Using artificial neural network to predict mortality of radical cystectomy for bladder cancer\u2019, Proceedings of International Conference on Smart Computing, SMARTCOMP 2014, 201\u2013207, (2014). https:\/\/doi.org\/10.1109\/SMARTCOMP.2014.7043859","DOI":"10.1109\/SMARTCOMP.2014.7043859"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29043-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29043-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29043-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:56:46Z","timestamp":1781629006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29043-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29043"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29043-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2847"}}